Norris Medicines Limited (BOM:524414)
India · Delayed Price · Currency is INR 13.00
-1.00 (-7.14%)
At close: Mar 6, 2026
Norris Medicines Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | - | 0.4 | 0.38 | 0.2 | 0.19 | 0.21 |
Cash & Short-Term Investments | 0.65 | 0.4 | 0.38 | 0.2 | 0.19 | 0.21 |
Cash Growth | 234.72% | 5.87% | 84.82% | 9.12% | -10.08% | -67.38% |
Accounts Receivable | - | 14.09 | 10.61 | 11 | 10.92 | 17.88 |
Receivables | - | 21.71 | 17.72 | 11 | 10.92 | 17.88 |
Inventory | - | 41.28 | 43.34 | 32.05 | 24.26 | 53.17 |
Prepaid Expenses | - | - | - | - | 0.38 | 0.23 |
Other Current Assets | - | - | - | 5.95 | 6.98 | 10.84 |
Total Current Assets | - | 63.39 | 61.43 | 49.2 | 42.73 | 82.33 |
Property, Plant & Equipment | - | 52.68 | 57.86 | 64.69 | 70.69 | 76.71 |
Long-Term Investments | - | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 |
Long-Term Deferred Tax Assets | - | 9.04 | 9.63 | 10.52 | 16.09 | 26.87 |
Other Long-Term Assets | - | -0 | 0 | 12.32 | 12.27 | 11.8 |
Total Assets | - | 138.1 | 141.87 | 136.86 | 141.91 | 197.87 |
Accounts Payable | - | 25.7 | 17.76 | 13.8 | 13.25 | 52.41 |
Accrued Expenses | - | 31.64 | 30.57 | 29.83 | 22.51 | 10.16 |
Short-Term Debt | - | 30.53 | 29.32 | 29.79 | 29.76 | 28.62 |
Other Current Liabilities | - | 13.63 | 14.6 | 3.62 | 2.31 | 25.74 |
Total Current Liabilities | - | 101.5 | 92.26 | 77.05 | 67.84 | 116.94 |
Long-Term Debt | - | 185.27 | 185.92 | 184.25 | 181.01 | 155.23 |
Other Long-Term Liabilities | - | 0 | 0 | - | 0 | 0 |
Total Liabilities | - | 286.77 | 278.17 | 261.3 | 248.85 | 272.17 |
Common Stock | - | 99.26 | 99.26 | 99.26 | 99.26 | 99.26 |
Retained Earnings | - | -247.93 | -235.56 | -223.69 | -206.2 | -173.56 |
Comprehensive Income & Other | - | 0 | 0 | - | - | - |
Shareholders' Equity | -158.96 | -148.68 | -136.3 | -124.43 | -106.94 | -74.3 |
Total Liabilities & Equity | - | 138.1 | 141.87 | 136.86 | 141.91 | 197.87 |
Total Debt | 214.72 | 215.8 | 215.24 | 214.04 | 210.77 | 183.85 |
Net Cash (Debt) | -214.07 | -215.41 | -214.86 | -213.84 | -210.58 | -183.65 |
Net Cash Per Share | -21.18 | -21.54 | -21.48 | -21.38 | -21.06 | -18.36 |
Filing Date Shares Outstanding | 9.96 | 10 | 10 | 10 | 10 | 10 |
Total Common Shares Outstanding | 9.96 | 10 | 10 | 10 | 10 | 10 |
Working Capital | - | -38.11 | -30.83 | -27.84 | -25.11 | -34.61 |
Book Value Per Share | -15.94 | -14.87 | -13.63 | -12.44 | -10.69 | -7.43 |
Tangible Book Value | -158.96 | -148.68 | -136.3 | -124.43 | -106.94 | -74.3 |
Tangible Book Value Per Share | -15.94 | -14.87 | -13.63 | -12.44 | -10.69 | -7.43 |
Land | - | 5.84 | 5.84 | 5.84 | 5.84 | 5.84 |
Buildings | - | 58.5 | 58.5 | 58.5 | 58.5 | 58.5 |
Machinery | - | 213.27 | 213.08 | 215.2 | 214.9 | 214.35 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.